Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • NEW STRATEGIES FOR STEM CELL MOBILIZATION

    Roberto Lemoli
    e2012066
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.066
    2668
    PDF: 1004
    HTML: 2591
  • EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?

    Pellegrino Musto, Dr. Nicola Sgherza
    e2024073
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.073
    1725
    PDF: 931
    HTML: 376
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1275
    PDF: 861
    HTML: 607
  • Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

    Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci
    e2024041
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.041
    1388
    PDF: 1142
    Suppl. Files: 757
    HTML: 100
  • CURING HEMOGLOBINOPATHIES: CHALLENGES AND ADVANCES OF CONVENTIONAL AND NEW GENE THERAPY APPROACHES.

    Irene Motta, Valentina Ghiaccio, Andrea Cosentino, Laura Breda
    e2019067
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.067
    3256
    PDF: 1984
    HTML: 980
  • Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analy

    Gianluca Cavallaro
    e2024049
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.049
    2370
    HTML: 164
    PDF: 1230
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3619
    PDF: 1790
    HTML: 1854
  • AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA

    Gert J. Ossenkoppele, Jeroen J.W.M. Janssen, Peter C. Huijgens
    e2013018
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.018
    2667
    PDF: 933
    HTML: 3305
  • THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone

    George J Kontoghiorghes, Marios Kleanthous, Christina N. Kontoghiorghe
    e2020011
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.011
    2790
    PDF: 1715
    HTML: 751
  • Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience

    Edoardo Olivari
    e2025040
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.040
    1234
    PDF: 858
    HTML: 221
  • BONE MARROW HOMING AND ENGRAFTMENT DEFECTS OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

    Giovanni Caocci, Giorgio La Nasa
    e2017032
    2017-04-19
    https://doi.org/10.4084/mjhid.2017.032
    3798
    PDF: 1709
    HTML: 3115
  • NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

    Dimitar Efremov, Adrian Wiestner, Luca Laurenti
    e2012067
    2012-10-09
    https://doi.org/10.4084/mjhid.2012.067
    2748
    PDF: 941
    HTML: 9092
    Efremov 1: 291
    Efremov 2: 262
  • TREOSULFAN-BASED CONDITIONING REGIMEN IN SIBLING AND ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE

    Antonio Marzollo, Elisabetta Calore, Manuela Tumino, Marta Pillon, Maria Vittoria Gazzola, Roberta Destro, Raffaella Colombatti, Piero Marson, Tiziana Tison, Anna Colpo, Chiara Mainardi, Maria Gabelli, Maria Paola Boaro, Sara Rossin, Aurora Strano, Nadia Quaglia, Federica Menzato, Giuseppe Basso, Laura Sainati, Chiara Messina
    e2017014
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.014
    4609
    PDF: 1688
    HTML: 1279
  • THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

    Ignazio Majolino
    e2017031
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.031
    2618
    PDF: 1110
    HTML: 2149
  • AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?

    Fabienne McClanahan, Peter Dreger
    e2012071
    2012-11-06
    https://doi.org/10.4084/mjhid.2012.071
    2676
    PDF: 915
    HTML: 1794
  • THE JAK2V617F POINT MUTATION INCREASES THE OSTEOCLAST FORMING ABILITY OF MONOCYTES IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS AND MAKES THEIR OSTEOCLASTS MORE SUSCEPTIBLE TO JAK2 INHIBITION

    Emmanouil Spanoudakis, Menelaos Papoutselis, Ioanna Bazntiara, Eleftheria Lamprianidou, Xrisa Kordella, Constantinos Tilkeridis, Constantinos Tsatalas, Ioannis Kotsianidis
    e2018058
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.058
    1504
    PDF: 955
    HTML: 227
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2539
    PDF: 1966
    HTML: 1098
  • ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Angelo Michele Carella
    e2012059
    2012-10-02
    https://doi.org/10.4084/mjhid.2012.059
    2203
    PDF: 1006
    HTML: 1120
  • HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation

    Anna Maria Testi
    e2022038
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.038
    1479
    PDF: 950
    HTML: 286
  • IN UTERO HAEMATOPOIETIC STEM CELL TRANSPLANTATION (IUHSCT)

    Maria Concetta Renda, Aurelio Maggio
    e2009031
    2009-12-29
    1438
    PDF: 524
    HTML: 1048
  • GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE

    Lang Peng, Lixin Zou, Xiaoliu Liu
    e2025012
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.012
    1182
    PDF: 1096
    Suppl. Files: 692
    HTML: 210
  • EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome

    Cumali Yalçın, Bedrettin Orhan, Tuba Ersal, Mümin Şentürk, Vildan Özkocaman, Halis Akalın, Fahir Özkalemkaş
    e2026032
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.032
    1155
    PDF: 912
    HTML: 358
  • ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

    Marco Gabbianelli, Ugo Testa
    e2009009
    2009-11-12
    1383
    PDF: 548
    HTML: 4645
  • HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PAEDIATRIC PATIENTS WITH X-LINKED LYMPHOPROLIFERATIVE SYNDROME

    Yuan Sun
    e2024036
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.036
    1502
    PDF: 1249
    HTML: 211
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    874
    PDF: 676
    HTML: 70
  • NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

    Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi
    e2019002
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.002
    7323
    PDF: 3891
    HTML: 869
  • CLASSICAL HODGKIN LYMPHOMA TODAY

    Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus
    e2026055
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.055
    1202
    PDF: 729
    HTML: 280
  • CHEMOTHERAPY-INDUCED NEUTROPENIA IN HIV POSITIVE PATIENTS WITH LYMPHOMA: COMPARISON OF PEGFILGRASTIM WITH DAILY FILGRASTIM ADMINISTRATION.

    Luciana Teofili, Immacolata Izzi, Eugenia Rosa Nuzzolo, Giancarlo Scoppettuolo, Katleen de Gaetano Donati, Lorenza Torti, Marianna Rossi
    e2012062
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.062
    1814
    PDF: 818
    HTML: 1690
  • NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS

    Maria Laura Bisegna, Nadia Peragine, Loredana Elia, Mabel Matarazzo, Maria Laura Milani, Stefania Intoppa, Mariangela Di Trani, Francesco Malfona, Maurizio Martelli, Maria Stefania De Propris
    e2024018
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.018
    1178
    PDF: 1411
    Suppl. Files: 880
    HTML: 205
  • HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients

    Wenshan Yang, Wei Dong
    e2025029
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.029
    3421
    PDF: 1156
    HTML: 359
    Suppl. Files: 550
  • THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

    Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra
    e2011031
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.031
    2510
    PDF: 1066
    HTML: 2523
  • THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN

    Donato Rigante
    e2018067
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.067
    2351
    PDF: 1416
    HTML: 1151
  • Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab: a Case Report

    Pier Luigi Zinzani, Flavia Salvatore, Beatrice Casadei, Camilla Mazzoni, Marianna Gentilini, Giulia Gabrielli, Lisa Argnani
    e2026052
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.052
    440
    PDF: 348
    HTML: 67
  • BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

    Maria Teresa Voso, Giulia Falconi, Dr. Fabiani
    e2023055
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.055
    2128
    PDF: 1157
    HTML: 292
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2792
    PDF: 910
    HTML: 5411
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

    Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani
    e2012069
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.069
    2750
    PDF: 830
    HTML: 1664
  • CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA

    Michele Bibas, Jorge J Castillo
    e2014064
    2014-10-22
    https://doi.org/10.4084/mjhid.2014.064
    2786
    PDF: 1777
    HTML: 2478
    Table1: 321
  • LIGHT CHAIN AMYLOIDOSIS

    Paolo Milani, Giampaolo Merlini, Giovanni Palladini
    e2018022
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.022
    6645
    PDF: 2538
    HTML: 1595
  • Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia

    Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi
    e2026003
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.003
    755
    PDF: 632
    Html: 269
  • COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA

    Sanjeev Kumar Sharma, Dharma Choudhary, Nitin Gupta, Mayank Dhamija, Vipin Khandelwal, Gaurav Kharya, Anil Handoo, Rasika Setia, Arpita Arora
    e2014046
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.046
    2977
    PDF: 1070
    HTML: 4763
  • OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism

    Ugo Testa, Elvira Pelosi, Germana Castelli
    e2025067
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.067
    2628
    PDF: 1484
    Html: 1148
  • TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS

    Lorenzo Zammarchi, Filippo Bartalesi, Alessandro Bartoloni
    e2014043
    2014-05-31
    https://doi.org/10.4084/mjhid.2014.043
    3766
    PDF: 1446
    HTML: 6379
  • PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

    Lucia De Franceschi
    e2009024
    2009-12-26
    1210
    PDF: 701
    HTML: 11215
  • IRON METABOLISM IN THALASSEMIA AND SICKLE CELL DISEASE

    Raffaella Mariani, Paola Trombini, Matteo Pozzi, Alberto Piperno
    e2009006
    2009-10-27
    1799
    PDF: 738
    HTML: 43982
  • Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

    Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith
    e2017034
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.034
    2850
    PDF: 1148
    HTML: 1228
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2693
    PDF: 895
    HTML: 1770
1 - 46 of 46 items
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.